Regulation & governance

Boehringer Ingelheim is adding a third target to obesity treatment.

The Cyclospora Test Was Wrong. Public Trust Cannot Be

China Just Put a Bispecific ADC Into Esophageal Cancer

New York Had Cooling-Tower Rules. Legionnaires’ Still Broke Through.

The Novo Nordisk Foundation is going global on cardiometabolic disease.

India Approved Its First Dengue Vaccine. Access Is Still Unwritten.

Plastic in the coronary bloodstream: micro- and nanoplastics raise a new cardiovascular warning

Canada Chose An Ebola Travel Ban. WHO Warned Against It.

Military recruits appear to face far more sudden cardiac death than athletes. Screening still depends on the country
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
